ArticleCardiovascular diabetology2011

Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor α/γ agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome.

Barbara C Hansen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.